Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021

SELL
$57.62 - $95.6 $473,002 - $784,780
-8,209 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$41.43 - $77.09 $1,160 - $2,158
28 Added 0.34%
8,209 $595,000
Q3 2020

Nov 10, 2020

SELL
$30.88 - $37.94 $861,335 - $1.06 Million
-27,893 Reduced 77.32%
8,181 $310,000
Q2 2020

Aug 13, 2020

BUY
$18.95 - $35.43 $683,602 - $1.28 Million
36,074 New
36,074 $1.28 Million
Q3 2019

Nov 07, 2019

SELL
$20.03 - $40.08 $485,026 - $970,537
-24,215 Closed
0 $0
Q2 2019

Aug 01, 2019

BUY
$25.78 - $39.77 $105,698 - $163,057
4,100 Added 20.38%
24,215 $871,000
Q1 2019

May 08, 2019

BUY
$22.09 - $39.21 $106,032 - $188,208
4,800 Added 31.34%
20,115 $634,000
Q4 2018

Feb 01, 2019

BUY
$19.89 - $30.02 $304,615 - $459,756
15,315 New
15,315 $385,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.19B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.